Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Andres Jose Gomez-Aldana

Associate Professor

University of Cincinnati
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Since 2018, our program has utilized specific psychosocial criteria and a multidisciplinary approach to assess patients for liver transplant due to alcohol-associated liver disease (ALD), rather than the 6-month abstinence rule alone. If declined based on these criteria, specific recommendations are provided to patients and their providers regarding goals for re-referral to increase the potential for future transplant candidacy. Recommendations include engagement in treatment for alcohol use disorder, serial negative biomarker testing, and maintenance of abstinence from alcohol. In our current study, we evaluate the outcomes of patients with ALD, who were initially declined upon assessment and re-referred to our program. This is a retrospective cohort study that includes 98 patients with ALD, who were previously declined for liver transplantation and were subsequently re-referred for liver transplant assessment between May 1, 2018, and December 31, 2021. We assess the outcomes of patients who were re-referred including acceptance for transplantation following a second assessment. Of the 98 patients who were re-referred, 46 (46.9%) fulfilled the recommendations made and proceeded to further medical evaluation. Nine were eventually transplanted; others are listed and are waiting for transplant. The presence of a partner was independently associated with a higher rate of acceptance (OR 0.16, 95% CI: 0.03–0.97, p = 0.05). Most of the patients who did not proceed further (n = 52) were declined again due to ALD contraindications (n = 33, 63.4%), including ongoing drinking and lack of engagement in recommended addiction treatment. Others had medical contraindications (11.2%), clinically improved (6.1%), had adherence issues (5.1%), or lack of adequate support (2%). Patients with ALD previously declined for a liver transplant can be re-referred and successfully accepted for transplantation by fulfilling the recommendations made by the multidisciplinary team. Important factors including ongoing abstinence, engagement in addiction treatment, and social support are key for successful acceptance.

Year:

2023

Year:

2023

Collaborators (8)

Nazia Selzner

University Health Network

CANADA
View details

Khalid Alswat

Professor, Director of the Research Center

king saud university

SAUDI ARABIA
View details

Detlef Schuppan

institute of translational immunology and research center for immune therapy university medical center mainz germany

GERMANY
View details

Flavio Caprioli

Associate professor

Università degli Studi di Torino

ITALY
View details

Peter Jepsen

DVIP-external, Clinical Professor

Aarhus University

DENMARK
View details

Luca Elli

Ricercatori

Ospedale Policlinico San Martino

ITALY
View details

Elena Verdu

Professor

McMaster University

CANADA
View details

Maria Ines Pinto-Sanchez

Associate Professor

McMaster University

CANADA
View details